西宝生物
欢迎访问西宝生物科研产品官网 !

西宝生物

西宝生物中国生命科学领域优选的综合服务商

全国服务热线:400-021-8158

24小时短信服务: 13917439331

您是否在搜:核酸室温保存 | 二噁英检测 | 食品安全 | 玛卡提取物 | 维生素K2 | 修饰性PEG | 岩藻糖

西宝生物
当前位置:首页 » 全站搜索 » 搜 索:Ab
Nat Commu重大突破:发现全新的肺部免疫细胞
由于它们的功能,肺经常暴露在空气中携带的各种化合物中,有时有害,有时无害。肺免疫系统在决定是否启动免疫反应以维持呼吸功能方面起着关键作用。在某些情况下,免疫系统会对无害化合物产生反应,就像哮喘的发生一样。在这方面,列日大学(University of Liege)的研究人员在Fabrice Bureau教授和Thomas Marichal教授的指导下,此前发现肺中的特定细胞,即"间质巨噬细胞",可以预防哮喘的发生。然而,这些细胞只是初步的特征。[查看]
http://cxbio.com/Article/natcommuzdtpfxqxdfbm_1.html
Nat Med:编制人类肠道细菌的综合目录
人体消化道是成千上万种不同细菌菌株的家园。其中的许多细菌菌株是有益的,而其他的细菌菌株可导致健康问题,比如炎症性肠病。如今,在一项新的研究中,来自美国麻省理工学院和布罗德研究所的研究人员分离并保存了将近8000种这些细菌菌株的样本,同时也阐明了它们的遗传和代谢背景。相关研究结果发表在2019年9月的Nature Medicine期刊上,论文标题为“A library of human gut bacterial isolates paired with longitudinal multiomics data enables mechanistic microbiome research”。[查看]
http://cxbio.com/Article/natmedbzrlcdxjdzhml_1.html
Biomaterials:开发出一种无载体的多重基因编辑系统,可用于抗癌免疫疗法
在一项新的研究中,韩国科学技术研究院(KIST)的Mihue Jang博士及其团队和韩国世宗大学的Seokmann Hong教授及其团队开发出一种新的基因编辑系统,而且这种系统可同时抑制淋巴瘤细胞表面上表达的干扰免疫系统的蛋白和激活细胞毒性T淋巴细胞,因而可以用于抗癌免疫治疗中。相关研究结果近期发表在Biomaterials期刊上,论文标题为“A carrier-free multiplexed gene editing systemapplicable for suspension cells”。[查看]
http://cxbio.com/Article/biomaterialskfcyzwzt_1.html
Mol Cancer Res:克服胰腺癌耐药,新药组合让癌症之王低头认输
胰腺癌是最致命的癌症之一,一旦疾病扩散,患者平均存活不到一年,目前迫切需要评估更多的治疗靶点。化疗药物abemaciclib治疗乳腺癌是有效的,但对这种药物靶向治疗胰腺癌的临床前评价很少。Sidney Kimmel癌症中心-Jefferson Health (SKCC)的一项新研究提供了支持abemaciclib用于胰腺癌的证据,并提出了新的目标,可以提高该药物的疗效,并打破该疾病中常见的耐药性问题。这项研究于近日发表在《Molecular Cancer Research》杂志上。[查看]
http://cxbio.com/Article/molcancerreskfyxanyx_1.html
Science子刊:HIV疫苗新策略!利用抗独特型抗体激活表达广泛中和抗体的前体B细胞
诱导保护性的广泛中和抗体(broadly neutralizing antibody, bNAb)产生是成功接种疫苗的关键策略。然而,对于许多重要的全球性疾病,如艾滋病和流感,人们尚未实现高效的疫苗接种[查看]
http://cxbio.com/Article/sciencezkhivymxcllyk_1.html
Nat Immunol:研究揭示Foxp3缺失的情况,T细胞功能重组调节新机制
转录因子Foxp3缺失的调节性T细胞(Treg细胞)缺乏抑制功能,表现为效应T (Teff)细胞样表型。近日来自波士顿儿童医院免疫学科和哈佛医学院儿科的Talal A. Chatila发现,Foxp3缺乏使雷帕霉素(mTOR)复合物2 (mTORC2)信号通路的代谢检查点激酶靶蛋白失调,并引起有氧糖酵解和氧化磷酸化,相关研究成果发表在《Nature Immunology》上,题为"Functional reprogramming of regulatory T cells in the absence of Foxp3"。[查看]
http://cxbio.com/Article/natimmunolyjjsfoxp3q_1.html
Cell Metab意外发现:胰腺癌可能是胰岛素水平过高导致!
不列颠哥伦比亚大学的科学家首次证明了高胰岛素水平和胰腺癌之间的因果关系。在近日发表在《Cell Metabolism》杂志上的一项研究中,研究人员降低了易患胰腺癌小鼠的胰岛素水平,发现这些低水平的胰岛素可以保护小鼠不患胰腺癌。这些发现为早期发现和预防人类胰腺癌提供了希望。[查看]
http://cxbio.com/Article/cellmetabywfxyxaknsy_1.html
J Clin Endocrinol Metabol:增加体育锻炼并不能改善棕色脂肪组织的功能
格拉纳达大学(UGR)的研究人员进行的一项研究发现,与普遍的看法相反,较高水平的体力活动与较大的棕色脂肪组织(BAT)的体积或活动无关。BAT是一种热源器官,它燃烧葡萄糖和脂肪,以热的形式释放能量。[查看]
http://cxbio.com/Article/jclinendocrinolmetab_1.html
Nature突破:肠道微生物可能会影响ALS的进程
魏茨曼科学研究所的研究人员在老鼠身上进行的研究发现,肠道微生物(统称肠道微生物群)可能会影响肌萎缩侧索硬化症(ALS)的进程,也被称为卢伽雷氏症。研究人员发现,小鼠接受了某些肠道微生物株或已知由这些微生物分泌的物质后,一种类似ALS的疾病的进展变慢,初步结果表明,该菌群调节功能的发现可能适用于ALS患者,相关研究成果于近日发表在《Nature》上,题为"Potential roles of gut microbiome & metabolites in modulation of murine ALS"。[查看]
http://cxbio.com/Article/naturetpcdwswknhyxal_1.html
Diabetes Care:意料之外的发现!免疫疗法或会引发癌症患者患上糖尿病!
免疫检查点抑制剂(ICIs,Immune checkpoint inhibitors)是一种新型的癌症免疫疗法,其能利用患者自身的免疫系统来攻击癌细胞,然而在某些患者机体中,ICIs却会促进免疫系统攻击健康细胞,从而引发自身免疫性疾病,当胰腺β细胞被攻击后就会诱发1型糖尿病,近日,一项刊登在国际杂志Diabetes Care上的研究报告中,来自大阪大学的科学家们通过研究分析了使用免疫检查点抑制剂治疗所带来的预期之外的后果。[查看]
http://cxbio.com/Article/diabetescareylzwdfxm_1.html
Metabolomics:“被遗忘的器官”或有望帮助开发2型糖尿病新型疗法
近日,一项刊登在国际杂志Metabolomics上的研究报告中,来自英国雷丁大学的科学家们通过研究阐明了免疫紊乱和2型糖尿病之间的关联,相关研究结果表明,诸如脾脏等“被遗忘的器官”或能掌握疾病对机体影响的线索。[查看]
http://cxbio.com/Article/metabolomicsbywdqghy_1.html
基因泰克创新ADC获批治疗早期乳腺癌 验证临床开发新模式
4日,基因泰克(Genentech)宣布,美国FDA批准其抗体偶联药物Kadcyla(ado-trastuzumab emtansine)扩大适应症,作为术后辅助疗法,治疗HER2阳性,在接受新辅助疗法治疗后,依旧有残余病灶的早期乳腺癌患者。这一疗法的获批,不但为早期乳腺癌患者提供了一款新的治疗选择,而且验证了针对早期高危乳腺癌患者开展临床试验的新模式。[查看]
http://cxbio.com/Article/jytkcxadchpzlzqrxayz_1.html
AAT Bioquest 光谱学检测领域供应商
美国AAT Bioquest Inc.(前身是ABD Bioquest,Inc.)是一家为从事生命科学研究、诊断研发及药物开发的科学家研发、生产和销售生物分析研究试剂和试剂盒的公司。公司致力于光谱学检测领域,包括吸收(颜色),荧光和发光技术。AAT Bioquest的产品帮助全世界的科学家和生物医药研究者更好的了解生物化学,免疫学,细胞生物学和分子生物学等领域。[查看]
http://cxbio.com/Article/aatbioquestgpxjclyld_1.html
一种新方法或能有效抑制癌症放疗患者的皮肤纤维化
近日,一项刊登在国际杂志Nature Metabolism上的研究报告中,来自多伦多大学的科学家们通过研究开发了一种新方法,其能通过控制代谢模式潜在遏制皮肤的纤维化,皮肤纤维化是癌症患者接受放疗经常产生的一种副作用,其会影响癌症幸存者的生活质量。[查看]
http://cxbio.com/Article/yzxffhnyxyzazflhzdpf_1.html
最成功的单抗药物都有这9大特征
开发一种可带来重大医学进步的治疗性抗体通常需要复杂、漫长、成本高昂的过程。在开始生产单克隆抗体(mAb)时,还必须要考虑到许多标准。不过,通过预测药物发现过程的每个阶段存在的潜在挑战,仍然有可能优化一个抗体药物的上市机会。[查看]
http://cxbio.com/Article/zcgddkywdyz9dtz_1.html
记录总数:1009 | 页数:68  <...55565758596061626364...>  
推荐产品 more
脱落酸 Abscisic acid
脱落酸 Abscisic acid
十八烷基三甲基溴化铵(STAB)
十八烷基三甲基溴化铵(STAB)
LabAssay Creatinine肌氨酸酐定量检测试剂盒 [Jaffe’method]  研究用试剂
LabAssay Creatinine肌氨酸酐定量检测试剂盒 [Jaffe’method] 研究用试剂
LabAssay(R) 葡萄糖检测试剂盒(Mutarotase-GOD法)
LabAssay(R) 葡萄糖检测试剂盒(Mutarotase-GOD法)
Glycan Labeling Kits 多糖标记试剂盒
Glycan Labeling Kits 多糖标记试剂盒
2-AB Labeled N-Glycans 2-AB标记N-多糖
2-AB Labeled N-Glycans 2-AB标记N-多糖
2-AA标记N-多糖 2-AA Labeled N-Glycans
2-AA标记N-多糖 2-AA Labeled N-Glycans
APTS Labeled N-Glycans APTS标记N-多糖
APTS Labeled N-Glycans APTS标记N-多糖
2-AB Labeled O-Glycans 2-AB标记O-多糖
2-AB Labeled O-Glycans 2-AB标记O-多糖
Unlabeled N-Glycans 未标记N-多糖
Unlabeled N-Glycans 未标记N-多糖
2-AB多糖标记试剂盒
2-AB多糖标记试剂盒
细胞活性(荧光)测试盒 CellQuanti-Blue Cell Viability Assay Kits (货号:CQBL-048/CQBL-05K)
细胞活性(荧光)测试盒 CellQuanti-Blue Cell Viability Assay Kits (货号:CQBL-048/CQBL-05K)
Labnet FastPette V2 电动移液器
Labnet FastPette V2 电动移液器
Labnet  Mini LabRoller 混合仪  H5500-230V
Labnet Mini LabRoller 混合仪 H5500-230V
Labnet GyroMini 盘旋3-D混合仪, S0500-230V
Labnet GyroMini 盘旋3-D混合仪, S0500-230V
Labnet Orbit 1000多功能数字振荡器,S2030-1000-B-230V
Labnet Orbit 1000多功能数字振荡器,S2030-1000-B-230V
Labnet Orbit 300多功能数字螺旋混合仪, S2030-300-B-230V
Labnet Orbit 300多功能数字螺旋混合仪, S2030-300-B-230V
Labnet VX-200漩涡混合仪
Labnet VX-200漩涡混合仪
Adipocyte FABP Human ELISA, 人脂肪细胞型脂肪酸结合蛋白Elisa
Adipocyte FABP Human ELISA, 人脂肪细胞型脂肪酸结合蛋白Elisa
牛奶细菌污染度检测试剂,Color Table
牛奶细菌污染度检测试剂,Color Table
D-阿拉伯糖 D-Arabinose  (货号:107861)
D-阿拉伯糖 D-Arabinose (货号:107861)
L-阿拉伯糖 L-Arabinose (货号:107865)
L-阿拉伯糖 L-Arabinose (货号:107865)
(R,S)-N-Nitrosoanabasine
(R,S)-N-Nitrosoanabasine
(R,S)-N-Nitrosoanatabine
(R,S)-N-Nitrosoanatabine
NAT, (R,S)-N-Nitrosoanatabine
NAT, (R,S)-N-Nitrosoanatabine
NAB, (R,S)-N-Nitrosoanabasine
NAB, (R,S)-N-Nitrosoanabasine
NAB-d4
NAB-d4
rac-NAB-D-glucoside
rac-NAB-D-glucoside
Sodium Tetraborate Decahydrate
Sodium Tetraborate Decahydrate
Tetraborate pH Standard Solution
Tetraborate pH Standard Solution
Tetraborate pH Standard Solution
Tetraborate pH Standard Solution
Lithium Tetraborate Anhydrous
Lithium Tetraborate Anhydrous
Lithium Tetraborate Anhydrous
Lithium Tetraborate Anhydrous
Nicotinic Acid Absorbance/Transmission Standard 6mg/l
Nicotinic Acid Absorbance/Transmission Standard 6mg/l
Nicotinic Acid Absorbance/Transmission Standard 6mg/l
Nicotinic Acid Absorbance/Transmission Standard 6mg/l
Nicotinic Acid Absorbance/Transmission Standard 12mg/l
Nicotinic Acid Absorbance/Transmission Standard 12mg/l
Nicotinic Acid Absorbance/Transmission Standard 12mg/l
Nicotinic Acid Absorbance/Transmission Standard 12mg/l
Nicotinic Acid Absorbance/Transmission Standard 18mg/l
Nicotinic Acid Absorbance/Transmission Standard 18mg/l
Nicotinic Acid Absorbance/Transmission Standard 18mg/l
Nicotinic Acid Absorbance/Transmission Standard 18mg/l
Nicotinic Acid Absorbance/Transmission Standard 24mg/l
Nicotinic Acid Absorbance/Transmission Standard 24mg/l
Nicotinic Acid Absorbance/Transmission Standard 24mg/l
Nicotinic Acid Absorbance/Transmission Standard 24mg/l
Lithium Tetraborate, type II
Lithium Tetraborate, type II
Lithium Tetraborate, Granules
Lithium Tetraborate, Granules
Sodium Tetraborate
Sodium Tetraborate
USP Reagent Water System Suitability Standard
USP Reagent Water System Suitability Standard
0.5 mg/L C from USP Sucrose System Suitability Standard
0.5 mg/L C from USP Sucrose System Suitability Standard
0.5 mg/L C from USP 1,4-Benzoquinone System Suitability Standard
0.5 mg/L C from USP 1,4-Benzoquinone System Suitability Standard
USP System Suitability Set Reagent H2O, 0.5 mg/L C USP Sucrose,0.5 mg/L C USP 1,4- C6H4O2.
USP System Suitability Set Reagent H2O, 0.5 mg/L C USP Sucrose,0.5 mg/L C USP 1,4- C6H4O2.
System Suitability Set to USP;Reagent H2O, 0.5 mg/L C USP Sucrose,0.5 mg/L C USP 1,4- C6H4O2.
System Suitability Set to USP;Reagent H2O, 0.5 mg/L C USP Sucrose,0.5 mg/L C USP 1,4- C6H4O2.
System Suitability USP Set;2 x H2O,0.5 mg/L C Sucrose,0.5 mg/L C,C6H4O2,0.25 mg/L C NIST Sucrose
System Suitability USP Set;2 x H2O,0.5 mg/L C Sucrose,0.5 mg/L C,C6H4O2,0.25 mg/L C NIST Sucrose
System Suitability Set to USP;Reagent H2O, 0.5 mg/L C Sucrose,0.5 mg/L C 1,4-Benzoquinone.40mlbtls
System Suitability Set to USP;Reagent H2O, 0.5 mg/L C Sucrose,0.5 mg/L C 1,4-Benzoquinone.40mlbtls
System Suitability Set to JP;Reagent H2O,0.5 mg/L C from Sodium Dodecylbenzene Sulfonate
System Suitability Set to JP;Reagent H2O,0.5 mg/L C from Sodium Dodecylbenzene Sulfonate
USP Suitability Kit;Reagent H2O, 0.5 mg/L C from USP Sucrose,0.5 mg/L C from USP 1,4- C6H4O2
USP Suitability Kit;Reagent H2O, 0.5 mg/L C from USP Sucrose,0.5 mg/L C from USP 1,4- C6H4O2
USP System Suitability Set,Reagent H2O,0.5 mg/L C USP Sucrose,0.5 mg/L C USP 1,4- C6H4O2
USP System Suitability Set,Reagent H2O,0.5 mg/L C USP Sucrose,0.5 mg/L C USP 1,4- C6H4O2
USP System Suitability Set,Reagent H2O, 0.5 mg/L C USP Sucrose,0.5 mg/L C USP 1,4- C6H4O2
USP System Suitability Set,Reagent H2O, 0.5 mg/L C USP Sucrose,0.5 mg/L C USP 1,4- C6H4O2
USP System Suitability Set;Reagent H2O, 0.5 mg/L C from USP Sucrose,0.5 mg/L C from USP C6H4O2
USP System Suitability Set;Reagent H2O, 0.5 mg/L C from USP Sucrose,0.5 mg/L C from USP C6H4O2
USP System Suitability Kit;Reagent H2O, 0.5 mg/L C from USP Sucrose,0.5 mg/L C C6H4O2.
USP System Suitability Kit;Reagent H2O, 0.5 mg/L C from USP Sucrose,0.5 mg/L C C6H4O2.
USP System Suitability Set,Reagent H2O,0.5 mg/L C USP Sucrose,0.5 mg/L C USP 1,4- C6H4O2.
USP System Suitability Set,Reagent H2O,0.5 mg/L C USP Sucrose,0.5 mg/L C USP 1,4- C6H4O2.
USP System Suitability Set,2 x Reagent H2O,0.5 mg/L C USP Sucrose,0.5 mg/L C USP 1,4- C6H4O2.
USP System Suitability Set,2 x Reagent H2O,0.5 mg/L C USP Sucrose,0.5 mg/L C USP 1,4- C6H4O2.
USP System Suitability Set,Reagent H2O,0.5 mg/L C USP Sucrose,0.5 mg/L C USP 1,4- C6H4O2
USP System Suitability Set,Reagent H2O,0.5 mg/L C USP Sucrose,0.5 mg/L C USP 1,4- C6H4O2
USP System Suitability Kit;Reagent H2O, 0.5 mg/L C USP Sucrose,0.5 mg/L C C6H4O2.
USP System Suitability Kit;Reagent H2O, 0.5 mg/L C USP Sucrose,0.5 mg/L C C6H4O2.
USP System Suitability Reagent; H2O, 0.5 mg/L C USP Sucrose,0.5 mg/L C USP 1,4-Benzoquinone
USP System Suitability Reagent; H2O, 0.5 mg/L C USP Sucrose,0.5 mg/L C USP 1,4-Benzoquinone
USP System Suitability Set, 500mL Bottles
USP System Suitability Set, 500mL Bottles
USP System Suitability Kit;2 x Blanks,0.5 mg/L C USP Sucrose,0.5 mg/L C USP C6H4O2
USP System Suitability Kit;2 x Blanks,0.5 mg/L C USP Sucrose,0.5 mg/L C USP C6H4O2
USP System Suitability Kit;Reagent H2O, 0.5 mg/L C USP Sucrose,0.5 mg/L C from USP 1,4- C6H4O2.
USP System Suitability Kit;Reagent H2O, 0.5 mg/L C USP Sucrose,0.5 mg/L C from USP 1,4- C6H4O2.
USP System Suitability;Reagent H2O,0.500 mg/L C USP Sucrose,0.500 mg/L C USP 1,4- C6H4O2.
USP System Suitability;Reagent H2O,0.500 mg/L C USP Sucrose,0.500 mg/L C USP 1,4- C6H4O2.
USP System Suitability Set, Reagent H2O, 0.5 mg/L C USP Sucrose,0.5 mg/L C USP 1,4- C6H4O2.1Lbtls
USP System Suitability Set, Reagent H2O, 0.5 mg/L C USP Sucrose,0.5 mg/L C USP 1,4- C6H4O2.1Lbtls
USP System Suitability Kit;2 x Reagent H2O,0.5 mg/L CUSP Sucrose,0.500 mg/L C USP 1,4- C6H4O2.
USP System Suitability Kit;2 x Reagent H2O,0.5 mg/L CUSP Sucrose,0.500 mg/L C USP 1,4- C6H4O2.
System Suitability Set;Reagent H2O, 0.5 mg/L C USP Sucrose,0.5 mg/L C USP 1,4-Benzoquinone.1Lbtls
System Suitability Set;Reagent H2O, 0.5 mg/L C USP Sucrose,0.5 mg/L C USP 1,4-Benzoquinone.1Lbtls
TOC Standard USP System Suitability Solution 1 4-Benzoquinone (0.5mg/L C)
TOC Standard USP System Suitability Solution 1 4-Benzoquinone (0.5mg/L C)
TOC Standard USP System Suitability Solution 14-Benzoquinone (0.5mg/L C) acidified with HCl
TOC Standard USP System Suitability Solution 14-Benzoquinone (0.5mg/L C) acidified with HCl
TOC Standard USP System suitability Set: 1x RTOCW 1x RTOCRs 1x RTOCRss
TOC Standard USP System suitability Set: 1x RTOCW 1x RTOCRs 1x RTOCRss
TOC Standard Set (12 x USP System Suitability Sets Delivered at monthly intervals)
TOC Standard Set (12 x USP System Suitability Sets Delivered at monthly intervals)
TOC Standard Set (2 x USP System Suitability Sets Delivered at 6 monthly intervals)
TOC Standard Set (2 x USP System Suitability Sets Delivered at 6 monthly intervals)
TOC Standard Set (260 x USP System Suitability Sets Delivered at 2 weekly intervals)
TOC Standard Set (260 x USP System Suitability Sets Delivered at 2 weekly intervals)
TOC Standard Set (4 x USP System Suitability Sets Delivered at 3 monthly intervals)
TOC Standard Set (4 x USP System Suitability Sets Delivered at 3 monthly intervals)
TOC Standard Set (52 x USP System Suitability Sets Delivered at 2 weekly intervals)
TOC Standard Set (52 x USP System Suitability Sets Delivered at 2 weekly intervals)
Heavy Metals (Cd, Cr, Pb) in ABS Resin-Iow Concentration Pellet
Heavy Metals (Cd, Cr, Pb) in ABS Resin-Iow Concentration Pellet
Heavy Metals (Cd, Cr, Hg, Pb) in ABS Resin-Low Concentration Disk
Heavy Metals (Cd, Cr, Hg, Pb) in ABS Resin-Low Concentration Disk
Heavy Metals (Cd, Cr, Pb) in ABS Resin-Iow Concentration Disk
Heavy Metals (Cd, Cr, Pb) in ABS Resin-Iow Concentration Disk
Heavy Metals (Cd, Cr, Hg, Pb) in ABS Resin-Low Concentration Pellet
Heavy Metals (Cd, Cr, Hg, Pb) in ABS Resin-Low Concentration Pellet
Heavy Metals (Cd, Cr, Hg, Pb) in ABS Resin-High Concentration Disk
Heavy Metals (Cd, Cr, Hg, Pb) in ABS Resin-High Concentration Disk
Organic Pollutants in Japanese Seabass Tissue
Organic Pollutants in Japanese Seabass Tissue
Pesticides in Cabbage
Pesticides in Cabbage
Heavy Metals (Cd, Cr, Pb) in ABS Resin-high Concentration Pellet
Heavy Metals (Cd, Cr, Pb) in ABS Resin-high Concentration Pellet
Heavy Metals (Cd, Cr, Hg, Pb) in ABS Resin-high Concentration Pellet
Heavy Metals (Cd, Cr, Hg, Pb) in ABS Resin-high Concentration Pellet
Sucrose (Brix) Standard Stabilised 0%-1.332986
Sucrose (Brix) Standard Stabilised 0%-1.332986
Sucrose (Brix) Standard Stabilised 0%-1.332986
Sucrose (Brix) Standard Stabilised 0%-1.332986
Sucrose (Brix) Standard Stabilised 5%-1.340264
Sucrose (Brix) Standard Stabilised 5%-1.340264
Sucrose (Brix) Standard Stabilised 5%-1.340264
Sucrose (Brix) Standard Stabilised 5%-1.340264
Sucrose (Brix) Standard Stabilised 7%-1.343253
Sucrose (Brix) Standard Stabilised 7%-1.343253
Sucrose (Brix) Standard Stabilised 7%-1.343253
Sucrose (Brix) Standard Stabilised 7%-1.343253
Sucrose (Brix) Standard Stabilised 10%-1.347824
Sucrose (Brix) Standard Stabilised 10%-1.347824
Sucrose (Brix) Standard Stabilised 10%-1.347824
Sucrose (Brix) Standard Stabilised 10%-1.347824
Sucrose (Brix) Standard Stabilised 11.2%-1.349682
Sucrose (Brix) Standard Stabilised 11.2%-1.349682
Sucrose (Brix) Standard Stabilised 11.2%-1.349682
Sucrose (Brix) Standard Stabilised 11.2%-1.349682
Sucrose (Brix) Standard Stabilised 11.5%-1.350149
Sucrose (Brix) Standard Stabilised 11.5%-1.350149
Sucrose (Brix) Standard Stabilised 11.5%-1.350149
Sucrose (Brix) Standard Stabilised 11.5%-1.350149
Sucrose (Brix) Standard Stabilised 12.5%-1.35093
Sucrose (Brix) Standard Stabilised 12.5%-1.35093
Sucrose (Brix) Standard Stabilised 12.5%-1.35093
Sucrose (Brix) Standard Stabilised 12.5%-1.35093
Sucrose (Brix) Standard Stabilised 12%-1.350930
Sucrose (Brix) Standard Stabilised 12%-1.350930
Sucrose (Brix) Standard Stabilised 12%-1.350930
Sucrose (Brix) Standard Stabilised 12%-1.350930
Sucrose (Brix) Standard Stabilised 15%-1.355679
Sucrose (Brix) Standard Stabilised 15%-1.355679
Sucrose (Brix) Standard Stabilised 15%-1.355679
Sucrose (Brix) Standard Stabilised 15%-1.355679
Sucrose (Brix) Standard Stabilised 20%-1.363842
Sucrose (Brix) Standard Stabilised 20%-1.363842
Sucrose (Brix) Standard Stabilised 20%-1.363842
Sucrose (Brix) Standard Stabilised 20%-1.363842
Sucrose (Brix) Standard Stabilised 25%-1.372328
Sucrose (Brix) Standard Stabilised 25%-1.372328
Sucrose (Brix) Standard Stabilised 25%-1.372328
Sucrose (Brix) Standard Stabilised 25%-1.372328
Sucrose (Brix) Standard Stabilised 30%-1.381149
Sucrose (Brix) Standard Stabilised 30%-1.381149
Sucrose (Brix) Standard Stabilised 30%-1.381149
Sucrose (Brix) Standard Stabilised 30%-1.381149
Sucrose (Brix) Standard Stabilised 35%-1.390322
Sucrose (Brix) Standard Stabilised 35%-1.390322
Sucrose (Brix) Standard Stabilised 35%-1.390322
Sucrose (Brix) Standard Stabilised 35%-1.390322
Sucrose (Brix) Standard Stabilised 40%-1.39986
Sucrose (Brix) Standard Stabilised 40%-1.39986
Sucrose (Brix) Standard Stabilised 40%-1.39986
Sucrose (Brix) Standard Stabilised 40%-1.39986
Sucrose (Brix) Standard Stabilised 45%-1.409777
Sucrose (Brix) Standard Stabilised 45%-1.409777
Sucrose (Brix) Standard Stabilised 45%-1.409777
Sucrose (Brix) Standard Stabilised 45%-1.409777
Sucrose (Brix) Standard Stabilised 50%-1.420087
Sucrose (Brix) Standard Stabilised 50%-1.420087
Sucrose (Brix) Standard Stabilised 50%-1.420087
Sucrose (Brix) Standard Stabilised 50%-1.420087
Sucrose (Brix) Standard Stabilised 55%-1.43080
Sucrose (Brix) Standard Stabilised 55%-1.43080
Sucrose (Brix) Standard Stabilised 55%-1.43080
Sucrose (Brix) Standard Stabilised 55%-1.43080
Sucrose (Brix) Standard Stabilised 60%-1.441928
Sucrose (Brix) Standard Stabilised 60%-1.441928
Sucrose (Brix) Standard Stabilised 60%-1.441928
Sucrose (Brix) Standard Stabilised 60%-1.441928
Sucrose (Brix) Standard Stabilised 67.5%-1.459290
Sucrose (Brix) Standard Stabilised 67.5%-1.459290
Refractive Index at 20℃-1.34325 Stabilised Sucrose
Refractive Index at 20℃-1.34325 Stabilised Sucrose
Refractive Index at 20℃-1.34325 Stabilised Sucrose
Refractive Index at 20℃-1.34325 Stabilised Sucrose
Refractive Index at 20℃-1.34782 Stabilised Sucrose
Refractive Index at 20℃-1.34782 Stabilised Sucrose
Refractive Index at 20℃-1.34782 Stabilised Sucrose
Refractive Index at 20℃-1.34782 Stabilised Sucrose
Refractive Index at 20℃-1.34968 Stabilised Sucrose
Refractive Index at 20℃-1.34968 Stabilised Sucrose
Refractive Index at 20℃-1.34968 Stabilised Sucrose
Refractive Index at 20℃-1.34968 Stabilised Sucrose
Refractive Index at 20℃-1.35015 Stabilised Sucrose
Refractive Index at 20℃-1.35015 Stabilised Sucrose
Refractive Index at 20℃-1.35015 Stabilised Sucrose
Refractive Index at 20℃-1.35015 Stabilised Sucrose
Refractive Index at 20℃-1.35171 Stabilised Sucrose
Refractive Index at 20℃-1.35171 Stabilised Sucrose
Refractive Index @20℃-1.35171 Stabilised Sucrose
Refractive Index @20℃-1.35171 Stabilised Sucrose
Refractive Index at 20℃-1.35093 Stabilised Sucrose
Refractive Index at 20℃-1.35093 Stabilised Sucrose
Refractive Index @20℃-1.35093 Stabilised Sucrose
Refractive Index @20℃-1.35093 Stabilised Sucrose
Refractive Index at 20℃-1.35568 Stabilised Sucrose
Refractive Index at 20℃-1.35568 Stabilised Sucrose
Refractive Index @20℃-1.35568 Stabilised Sucrose
Refractive Index @20℃-1.35568 Stabilised Sucrose
Refractive Index at 20℃-1.36384 Stabilised Sucrose
Refractive Index at 20℃-1.36384 Stabilised Sucrose
Refractive Index @20℃-1.36384 Stabilised Sucrose
Refractive Index @20℃-1.36384 Stabilised Sucrose
Refractive Index at 20℃-1.37233 Stabilised Sucrose
Refractive Index at 20℃-1.37233 Stabilised Sucrose
Refractive Index @20℃-1.37233 Stabilised Sucrose
Refractive Index @20℃-1.37233 Stabilised Sucrose
Refractive Index at 20℃-1.38115 Stabilised Sucrose
Refractive Index at 20℃-1.38115 Stabilised Sucrose
Refractive Index @20℃-1.38115 Stabilised Sucrose
Refractive Index @20℃-1.38115 Stabilised Sucrose
Refractive Index at 20℃-1.39032 Stabilised Sucrose
Refractive Index at 20℃-1.39032 Stabilised Sucrose
Refractive Index @20℃-1.39032 Stabilised Sucrose
Refractive Index @20℃-1.39032 Stabilised Sucrose
Refractive Index at 20℃-1.39986 Stabilised Sucrose
Refractive Index at 20℃-1.39986 Stabilised Sucrose
Refractive Index @20℃-1.39986 Stabilised Sucrose
Refractive Index @20℃-1.39986 Stabilised Sucrose
Refractive Index at 20℃-1.40978 Stabilised Sucrose
Refractive Index at 20℃-1.40978 Stabilised Sucrose
Refractive Index @20℃-1.40978 Stabilised Sucrose
Refractive Index @20℃-1.40978 Stabilised Sucrose
Refractive Index at 20℃-1.42009 Stabilised Sucrose
Refractive Index at 20℃-1.42009 Stabilised Sucrose
Refractive Index @20℃-1.42009 Stabilised Sucrose
Refractive Index @20℃-1.42009 Stabilised Sucrose
Refractive Index at 20℃-1.43080 Stabilised Sucrose
Refractive Index at 20℃-1.43080 Stabilised Sucrose
Refractive Index @20℃-1.43080 Stabilised Sucrose
Refractive Index @20℃-1.43080 Stabilised Sucrose
Refractive Index at 20℃-1.44193 Stabilised Sucrose
Refractive Index at 20℃-1.44193 Stabilised Sucrose
Refractive Index @20℃-1.44193 Stabilised Sucrose
Refractive Index @20℃-1.44193 Stabilised Sucrose
N-亚硝基假木贼碱 (NAB)
N-亚硝基假木贼碱 (NAB)
Hydrogen Peroxide 10% w/v stabilised
Hydrogen Peroxide 10% w/v stabilised
TISAB for wine analysis (Dir. 2676/90) for the fluoride determination by selective electrodes.
TISAB for wine analysis (Dir. 2676/90) for the fluoride determination by selective electrodes.
ABTS
ABTS
DTAB;十二烷基三甲基溴化铵
DTAB;十二烷基三甲基溴化铵
CTAB;十六烷基三甲基溴化铵
CTAB;十六烷基三甲基溴化铵
TTAB;十四烷基三甲基溴化铵
TTAB;十四烷基三甲基溴化铵
十八烷基三甲基溴化铵(STAB)
十八烷基三甲基溴化铵(STAB)
Glycerol-3-phosphate Dehydrogenase,from rabbit muscle, suspension
Glycerol-3-phosphate Dehydrogenase,from rabbit muscle, suspension
L-Lactate Dehydrogenase (L-LDH)from rabbit muscle, suspension
L-Lactate Dehydrogenase (L-LDH)from rabbit muscle, suspension
Pyruvate Kinase,from rabbit muscle, suspension
Pyruvate Kinase,from rabbit muscle, suspension
Triose-phosphate Isomerase,from rabbit muscle, suspension
Triose-phosphate Isomerase,from rabbit muscle, suspension
Pefabloc SC (AEBSF)
Pefabloc SC (AEBSF)
2,2'-azino-bis(3-ethylbenzthiazoline) 6-sulphonic acid (ABTS),solution
2,2'-azino-bis(3-ethylbenzthiazoline) 6-sulphonic acid (ABTS),solution
Ethyclozate metabolite (CIA:5-Chloro-3 (1H)-indazolacetate)
Ethyclozate metabolite (CIA:5-Chloro-3 (1H)-indazolacetate)
N-Nitrosoanatabine 2,4,5,6 D4, 10ng/ul 于丙酮
N-Nitrosoanatabine 2,4,5,6 D4, 10ng/ul 于丙酮
European Pharmacopoeia Reagent 0.1M Tetrabutylammonium Hydroxide
European Pharmacopoeia Reagent 0.1M Tetrabutylammonium Hydroxide
European Pharmacopoeia Reagent 0.1M Tetrabutylammonium Hydroxide in 2-propanol
European Pharmacopoeia Reagent 0.1M Tetrabutylammonium Hydroxide in 2-propanol
EDDP perchlorate (Methadone metabolite),100ug/mL (as pyrolinium) 于甲醇
EDDP perchlorate (Methadone metabolite),100ug/mL (as pyrolinium) 于甲醇
EDDP perchlorate (Methadone metabolite),1.0mg/mL (as pyrrolinium) 于甲醇
EDDP perchlorate (Methadone metabolite),1.0mg/mL (as pyrrolinium) 于甲醇
Gabapentin,1.0mg/mL 于甲醇
Gabapentin,1.0mg/mL 于甲醇
MAB<AFP>M-LJ738-IGG
MABM-LJ738-IGG
MAB<AFP>M-TU11-IGG
MABM-TU11-IGG
MAB<CEA>M-TU2-IGG Carcinoembryonic antigen
MABM-TU2-IGG Carcinoembryonic antigen
MAB<CEA>M-TU3-IGG
MABM-TU3-IGG
MAB<CK-MB> M-7.4.5 IGG
MAB M-7.4.5 IGG
MAB<CK-MB> M-6.12.47 IGG
MAB M-6.12.47 IGG
Mab<CK-MM> Mix creatinine kinase isoenzyme MM
Mab Mix creatinine kinase isoenzyme MM
MAB<DD>M-1.2.57 IgG
MAB
M-1.2.57 IgG
MAB<DD>M-2.1.16 IgG,Human fibrinogen cleavage product D-Dimer
MAB
M-2.1.16 IgG,Human fibrinogen cleavage product D-Dimer
MAB<Ferr>M-3.170-IgG,Human liver ferritin
MABM-3.170-IgG,Human liver ferritin
MAB<Ferr>M-4.184-IgG
MABM-4.184-IgG
MAB<HCG>M-INN22-IgG Human chorionic gonadotropin b-chain
MABM-INN22-IgG Human chorionic gonadotropin b-chain
MAB<HCG>M-INN2-IgG
MABM-INN2-IgG
MAB<H-S-Amy>M-Tu66C7-IgG salivary α-amylase
MABM-Tu66C7-IgG salivary α-amylase
MAB<H-S-Amy>M-Tu88E8-IgG
MABM-Tu88E8-IgG
MAB<IGE>M-323-IgG
MABM-323-IgG
MAB<IGE>M-7H8-IGG
MABM-7H8-IGG
MAB<INSULIN>M-BM1-IgG
MABM-BM1-IgG
MAB<INSULIN>M-ST3-IgG
MABM-ST3-IgG
MAB<LH>M-11412-IgG Luteinizing hormone
MABM-11412-IgG Luteinizing hormone
MAB<LH>M-2.406-IgG
MABM-2.406-IgG
MAB<PRL>M-C4E4-IGG,Prolactin
MABM-C4E4-IGG,Prolactin
MAB<PRL>M-H12G10-IGG
MABM-H12G10-IGG
MAB<TSH>M-TU1.20-IGG
MABM-TU1.20-IGG
PAB<CRP>S-Ig,Human C-reactive protein
PABS-Ig,Human C-reactive protein
PAB<T3>S-IGG,trijodothyronine
PABS-IGG,trijodothyronine
PAB<T4>S-IGG
PABS-IGG